Diagnostics News: Qiagen Companion Dx; Ortho-Clinical Agreement; BD 510(k)s
This article was originally published in The Gray Sheet
Executive Summary
Qiagen will co-develop and commercialize a companion diagnostic for AstraZeneca’s Iressa lung-cancer drug under an agreement between the firms. Ortho-Clinical Diagnostics will sell a test system for acute kidney injury. BD nabs 510(k)s for STD assays.